FDA Inspection 1233595 — Community Blood Center
The FDA completed an inspection of Community Blood Center on Mar 13, 2024 in Kettering, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Kettering, OH (United States)